SSPL Securities Private Limited

Wednesday 18 Jun, 2025 07:54 PM

Reliance Infra jumps after landmark Dassault jet deal Ratnabhumi Developers jumps 108% in fourteen days Indusind Bank jumps on brokerage upgrade Orient Cement Ltd leads losers in 'A' group GTV Engg rises after securing Rs 2-cr export order from Metso India KBC Global Ltd leads losers in 'B' group Volumes spurt at Hindustan Zinc Ltd counter Sakar Healthcare surges after receiving marketing authorization in EU for its oncology product Steel Authority of India Ltd slips for fifth straight session Hathway Cable & Datacom Ltd slips for fifth straight session NLC India Ltd down for fifth straight session Petronet LNG Ltd drops for fifth straight session Exide Industries Ltd down for fifth straight session Tata Motors Ltd slips for fifth straight session Samvardhana Motherson International Ltd down for fifth straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Alembic Pharma receives USFDA EIR for Karakhadi API facility

18-Jun-25 12:51 Hrs IST

The inspection was conducted at the API-III facility from 17th March 2025 to 21st March 2025.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world. Its research and manufacturing facilities are approved by regulatory authorities of many developed countries, including the USFDA.

The company's consolidated net profit declined 12% to Rs 156.89 crore despite a 16.7% jump in net sales to Rs 1,769.64 crore in Q4 FY25 over Q4 FY24.

Shares of Alembic Pharmaceuticals shed 0.78% to Rs 962.70 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 42036060

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)